Ciprofloxacin Alvogen (Ciprofloxacin Portfarma) Filmuhúðuð tafla 500 mg Iceland - Icelandic - LYFJASTOFNUN (Icelandic Medicines Agency)

ciprofloxacin alvogen (ciprofloxacin portfarma) filmuhúðuð tafla 500 mg

alvogen ehf. - ciprofloxacinum hýdróklóríð - filmuhúðuð tafla - 500 mg

Ciprofloxacin Alvogen (Ciprofloxacin Portfarma) Filmuhúðuð tafla 250 mg Iceland - Icelandic - LYFJASTOFNUN (Icelandic Medicines Agency)

ciprofloxacin alvogen (ciprofloxacin portfarma) filmuhúðuð tafla 250 mg

alvogen ehf. - ciprofloxacinum hýdróklóríð - filmuhúðuð tafla - 250 mg

Síprox Tafla 250 mg Iceland - Icelandic - LYFJASTOFNUN (Icelandic Medicines Agency)

síprox tafla 250 mg

teva b.v.* - ciprofloxacinum hýdróklóríð - tafla - 250 mg

Síprox Tafla 500 mg Iceland - Icelandic - LYFJASTOFNUN (Icelandic Medicines Agency)

síprox tafla 500 mg

teva b.v.* - ciprofloxacinum hýdróklóríð - tafla - 500 mg

Zitromax Stofn fyrir innrennslisþykkni, lausn 500 mg Iceland - Icelandic - LYFJASTOFNUN (Icelandic Medicines Agency)

zitromax stofn fyrir innrennslisþykkni, lausn 500 mg

pfizer aps - azithromycinum díhýdrat - stofn fyrir innrennslisþykkni, lausn - 500 mg

Epysqli European Union - Icelandic - EMA (European Medicines Agency)

epysqli

samsung bioepis nl b.v. - eculizumab - blóðrauði, ofsakláði - Ónæmisbælandi lyf - epysqli is indicated in adults and children for the treatment of paroxysmal nocturnal haemoglobinuria (pnh). evidence of clinical benefit is demonstrated in patients with haemolysis with clinical symptom(s) indicative of high disease activity, regardless of transfusion history.

Bekemv European Union - Icelandic - EMA (European Medicines Agency)

bekemv

amgen technology (ireland) uc - eculizumab - blóðrauði, ofsakláði - Ónæmisbælandi lyf - bekemv is indicated in adults and children for the treatment of paroxysmal nocturnal haemoglobinuria (pnh). sönnunargögn klínískum gagn er sýnt í sjúklinga með haemolysis með klínískum einkenni(s) marks um hár sjúkdómur starfsemi, óháð blóðgjöf sögu (sjá kafla 5.

Protopic European Union - Icelandic - EMA (European Medicines Agency)

protopic

leo pharma a/s - takrólímus - dermatitis, atópísk - aðrar húðsjúkdómar - flare treatmentadults and adolescents (16 years of age and above)treatment of moderate to severe atopic dermatitis in adults who are not adequately responsive to or are intolerant of conventional therapies such as topical corticosteroids. children (two years of age and above)treatment of moderate to severe atopic dermatitis in children (two years of age and above) who failed to respond adequately to conventional therapies such as topical corticosteroids. maintenance treatmentmaintenance treatment of moderate to severe atopic dermatitis for the prevention of flares and the prolongation of flare-free intervals in patients experiencing a high frequency of disease exacerbations (i. koma fjórir eða meira sinnum á ári) sem hafa haft fyrstu viðbrögð við sex vikur meðferð tvisvar á dag takrólímus smyrslið (sár ruddi, næstum ruddi eða dálítið áhrifum).

Enjaymo European Union - Icelandic - EMA (European Medicines Agency)

enjaymo

sanofi b.v. - sutimlimab - hemolysis; anemia, hemolytic, autoimmune - Ónæmisbælandi lyf - enjaymo is indicated for the treatment of haemolytic anaemia in adult patients with cold agglutinin disease (cad).

Amoxicillin Mylan (Amoxicillin Mylan) Tafla 750 mg Iceland - Icelandic - LYFJASTOFNUN (Icelandic Medicines Agency)

amoxicillin mylan (amoxicillin mylan) tafla 750 mg

viatris limited - amoxicillinum tríhýdrat - tafla - 750 mg